James Aloysius Brady
Director, Verona Pharma.
Companies
- Xeris Biopharma Holdings, Inc.Board member Mar 28, 2025 to now1
- Verona PharmaBoard member Mar 16, 2022 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Xeris Biopharma Holdings, Inc. XERS113,359 shares3$1.3M at $11.04Jun 4, 2026
Verona Pharma VRP0 shares4Oct 7, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 4, 2026Granted 24,193 shares of Xeris Biopharma Holdings, Inc.3
- Mar 30, 2026Sold 10,834 shares at $5.54 of Xeris Biopharma Holdings, Inc.5
- Oct 7, 2025Returned to company 72,000 shares of Verona Pharma4
- Oct 7, 2025Exercised options 72,000 shares of Verona Pharma4
- Oct 7, 2025Returned to company 23,176 shares of Verona Pharma4
- Aug 1, 2025Sold 824 shares at $13.14 of Verona Pharma6
- Aug 1, 2025Exercised options 24,000 shares of Verona Pharma6
- Mar 28, 2025Granted 100,000 shares of Xeris Biopharma Holdings, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARVerona Pharma, Board member
- 3
- 4
- 5SEC EDGARForm 4 filed Apr 1, 2026
- 6SEC EDGARForm 4 filed Aug 5, 2025
- 7SEC EDGARForm 4 filed Mar 28, 2025